vs

Side-by-side financial comparison of MARCHEX INC (MCHX) and RETRACTABLE TECHNOLOGIES INC (RVP). Click either name above to swap in a different company.

MARCHEX INC is the larger business by last-quarter revenue ($10.8M vs $9.4M, roughly 1.1× RETRACTABLE TECHNOLOGIES INC). MARCHEX INC runs the higher net margin — -21.4% vs -24.9%, a 3.5% gap on every dollar of revenue. On growth, RETRACTABLE TECHNOLOGIES INC posted the faster year-over-year revenue change (4.0% vs -9.0%). Over the past eight quarters, RETRACTABLE TECHNOLOGIES INC's revenue compounded faster (11.5% CAGR vs -3.2%).

Marchex Inc. is a U.S.-headquartered technology company focused on conversational analytics, call tracking, and digital marketing solutions for small and medium-sized businesses as well as enterprise clients across North America. Its core products help businesses optimize customer acquisition strategies, quantify marketing campaign performance, and improve customer engagement across voice and digital communication channels.

Retractable Technologies Inc is a specialized medical device manufacturer that designs, manufactures and distributes safety-engineered disposable medical products, including retractable syringes, safety needles and IV catheters. Its key customers are healthcare facilities, pharmaceutical companies and public health agencies across North America and global markets, helping reduce needlestick injury risks for medical personnel and patients.

MCHX vs RVP — Head-to-Head

Bigger by revenue
MCHX
MCHX
1.1× larger
MCHX
$10.8M
$9.4M
RVP
Growing faster (revenue YoY)
RVP
RVP
+13.0% gap
RVP
4.0%
-9.0%
MCHX
Higher net margin
MCHX
MCHX
3.5% more per $
MCHX
-21.4%
-24.9%
RVP
Faster 2-yr revenue CAGR
RVP
RVP
Annualised
RVP
11.5%
-3.2%
MCHX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MCHX
MCHX
RVP
RVP
Revenue
$10.8M
$9.4M
Net Profit
$-2.3M
$-2.3M
Gross Margin
61.6%
-16.2%
Operating Margin
-21.9%
-81.7%
Net Margin
-21.4%
-24.9%
Revenue YoY
-9.0%
4.0%
Net Profit YoY
-21.3%
-162.3%
EPS (diluted)
$-0.05
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MCHX
MCHX
RVP
RVP
Q4 25
$10.8M
$9.4M
Q3 25
$11.5M
$10.1M
Q2 25
$11.7M
$10.4M
Q1 25
$11.4M
$8.3M
Q4 24
$11.9M
$9.1M
Q3 24
$12.6M
$10.3M
Q2 24
$12.1M
$6.0M
Q1 24
$11.6M
$7.6M
Net Profit
MCHX
MCHX
RVP
RVP
Q4 25
$-2.3M
$-2.3M
Q3 25
$-1.0M
$371.0K
Q2 25
$84.0K
$-87.5K
Q1 25
$-2.0M
$-10.5M
Q4 24
$-1.9M
$3.8M
Q3 24
$-831.0K
$-1.9M
Q2 24
$-756.0K
$-14.2M
Q1 24
$-1.4M
$429.4K
Gross Margin
MCHX
MCHX
RVP
RVP
Q4 25
61.6%
-16.2%
Q3 25
63.1%
16.7%
Q2 25
65.1%
-1.0%
Q1 25
63.3%
-0.0%
Q4 24
63.2%
-27.5%
Q3 24
66.4%
-0.1%
Q2 24
65.6%
-7.0%
Q1 24
61.9%
25.0%
Operating Margin
MCHX
MCHX
RVP
RVP
Q4 25
-21.9%
-81.7%
Q3 25
-8.2%
-36.2%
Q2 25
-4.6%
-49.1%
Q1 25
-16.4%
-56.4%
Q4 24
-13.3%
-79.6%
Q3 24
-6.6%
-49.6%
Q2 24
-6.0%
-95.6%
Q1 24
-11.3%
-39.3%
Net Margin
MCHX
MCHX
RVP
RVP
Q4 25
-21.4%
-24.9%
Q3 25
-8.9%
3.7%
Q2 25
0.7%
-0.8%
Q1 25
-17.4%
-126.6%
Q4 24
-16.0%
41.6%
Q3 24
-6.6%
-18.6%
Q2 24
-6.3%
-234.9%
Q1 24
-12.5%
5.7%
EPS (diluted)
MCHX
MCHX
RVP
RVP
Q4 25
$-0.05
$-0.09
Q3 25
$-0.02
$0.01
Q2 25
$0.00
$0.00
Q1 25
$-0.05
$-0.35
Q4 24
$-0.04
$0.14
Q3 24
$-0.02
$-0.07
Q2 24
$-0.02
$-0.48
Q1 24
$-0.03
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MCHX
MCHX
RVP
RVP
Cash + ST InvestmentsLiquidity on hand
$9.9M
$2.6M
Total DebtLower is stronger
$895.6K
Stockholders' EquityBook value
$30.1M
$74.4M
Total Assets
$39.7M
$142.6M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MCHX
MCHX
RVP
RVP
Q4 25
$9.9M
$2.6M
Q3 25
$10.3M
$3.4M
Q2 25
$10.5M
$3.0M
Q1 25
$10.0M
$3.4M
Q4 24
$12.8M
$4.2M
Q3 24
$12.1M
$3.9M
Q2 24
$12.0M
$6.9M
Q1 24
$12.0M
$10.0M
Total Debt
MCHX
MCHX
RVP
RVP
Q4 25
$895.6K
Q3 25
Q2 25
Q1 25
Q4 24
$1.2M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MCHX
MCHX
RVP
RVP
Q4 25
$30.1M
$74.4M
Q3 25
$31.9M
$76.8M
Q2 25
$32.0M
$76.5M
Q1 25
$31.4M
$76.6M
Q4 24
$32.6M
$87.2M
Q3 24
$34.1M
$83.5M
Q2 24
$34.5M
$85.4M
Q1 24
$34.9M
$99.7M
Total Assets
MCHX
MCHX
RVP
RVP
Q4 25
$39.7M
$142.6M
Q3 25
$41.1M
$146.4M
Q2 25
$42.0M
$147.1M
Q1 25
$40.6M
$149.3M
Q4 24
$43.2M
$160.7M
Q3 24
$44.1M
$157.8M
Q2 24
$45.5M
$160.7M
Q1 24
$45.6M
$176.0M
Debt / Equity
MCHX
MCHX
RVP
RVP
Q4 25
0.01×
Q3 25
Q2 25
Q1 25
Q4 24
0.01×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MCHX
MCHX
RVP
RVP
Operating Cash FlowLast quarter
$121.0K
$-596.5K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MCHX
MCHX
RVP
RVP
Q4 25
$121.0K
$-596.5K
Q3 25
$290.0K
$-1.3M
Q2 25
$803.0K
$-3.7M
Q1 25
$-2.6M
$-1.5M
Q4 24
$875.0K
$-1.1M
Q3 24
$382.0K
$-5.7M
Q2 24
$117.0K
$-2.7M
Q1 24
$-2.5M
$-2.0M
Free Cash Flow
MCHX
MCHX
RVP
RVP
Q4 25
Q3 25
$-1.3M
Q2 25
$-4.1M
Q1 25
$-1.6M
Q4 24
$757.0K
$-1.4M
Q3 24
$199.0K
$-6.5M
Q2 24
$40.0K
$-2.8M
Q1 24
$-2.5M
$-2.2M
FCF Margin
MCHX
MCHX
RVP
RVP
Q4 25
Q3 25
-13.4%
Q2 25
-38.9%
Q1 25
-18.8%
Q4 24
6.3%
-15.5%
Q3 24
1.6%
-63.0%
Q2 24
0.3%
-46.8%
Q1 24
-21.4%
-29.6%
Capex Intensity
MCHX
MCHX
RVP
RVP
Q4 25
Q3 25
0.0%
0.9%
Q2 25
3.2%
Q1 25
1.0%
Q4 24
1.0%
3.3%
Q3 24
1.5%
7.7%
Q2 24
0.6%
2.0%
Q1 24
0.0%
3.0%
Cash Conversion
MCHX
MCHX
RVP
RVP
Q4 25
Q3 25
-3.39×
Q2 25
9.56×
Q1 25
Q4 24
-0.29×
Q3 24
Q2 24
Q1 24
-4.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons